Navigation Links
BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing
Date:3/30/2009

SAN ANTONIO, March 30 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a rapidly growing medical device company focused on the clinical development of orthopaedic memory metal implants, announced today that it has appointed Keith M. Peeples as its Vice President, Sales and Marketing.

BME specializes in nitinol implants that contract and compress bone after implantation, bringing bone ends together to promote bone union. The Orthopaedic Staple System (OSS)(TM) of proprietary staples and the patented OSSforce(TM) Controller allow the surgeon to finely control the amount of compression and rate of force application generated on bones, thereby reducing fractures and stimulate bone healing.

"Keith is a proven executive who brings extensive senior level sales and marketing experience to BME, as well as a shared strategic vision to create a leading medical device company," said Kenneth I. Moch, President and CEO of BME. "We are delighted to have Keith as part of our leadership team."

Mr. Peeples brings to BME over 25 years experience in sales, marketing and sales training in the healthcare industry. Prior to joining BME he was Vice President of Sales and Marketing at Advanced Bio-Surfaces, Inc., an orthopedic company that manufactures an interpositional knee implant system. From 1999 to 2006, Mr. Peeples was Vice President of Sales at The ASC Network, which offers a supply solution to physician owned or procedure based centers. From 1995-1998, Mr. Peeples was Director of Sales for North and South America at Medtronic / InStent, a provider of self-expanding nitinol stents for gastroenterology, urology, radiology and peripheral vascular procedures. Mr. Peeples also worked as the Western Regional Sales Manager and as an independent sales representative with Pentax Precision Instrument Corp., a provider of flexible endoscopes, from 1981 to 1995. Mr. Peeples has a B.A. in Biology from the
'/>"/>

SOURCE BioMedical Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
3. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
4. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
5. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
6. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
7. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
8. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
9. Environmental Tectonics Corporations BioMedical Division Announces New Contract
10. Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
11. Verax Biomedical Receives ISO Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 Bayer CropScience ... first Bayer Bee Care Community Leadership Award. The award ... Congressional Reception in Washington, D.C., an event where ... to the world’s food supply. , The Bayer ... harnessed the power of the honey bee colony to ...
(Date:6/19/2013)... India’s vast and growing population means ... up to a billion dollars per year by ... taking serious action to better regulate and oversee ... will examine:, ,     Recent changes in ... long term impacts ,     Foreseeable opportunities ...
(Date:6/18/2013)... Clara, CA (PRWEB) June 18, 2013 ... to standard size SEMs but have limited performance and ... lower resolution. Full size SEMs would normally provide better ... more knowledge to operate and have a higher cost ... address the gap between these two types of ...
(Date:6/18/2013)... The Regulatory Affairs Professionals Society ... in Asia—one in Singapore and one in Shanghai, China. ... Pan-Asia office , serving the Asia Pacific region, and ... within China. , The announcement comes just a few ... government agencies to develop and implement a new ...
Breaking Biology Technology:Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3
... BAX ) announced today that its Board of ... of the company,s,common stock to be executed upon completion ... less than $700 million of remaining authorization under its,previous ... March,2007. Shares will be repurchased in the open market ...
... 18 /PRNewswire/ - Aegera Therapeutics announced today,the ... trial for AEG33773, a,novel, orally bioavailable small ... diabetic neuropathy. The Phase I study will ... AEG33773 using a randomized,double blind, placebo controlled, ...
... siRNA Targeting of, VEGF Expression, Further Strengthening OPKO,s RNAi Intellectual Property ... ... OPKO Health, Inc. (Amex: OPK ),today announced that it has been ... for methods related to the use and,administration of small interfering RNAs (siRNAs) ...
Cached Biology Technology:Baxter's Board of Directors Approves New Share Repurchase Authorization of $2 Billion 2Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain 2OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib 2OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib 3OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib 4
(Date:6/19/2013)... new variety of canary seeds bred specifically for human ... ideal for people with celiac disease (CD), scientists have ... of Agricultural and Food Chemistry . , Joyce ... 3 million people in the United States alone have ... wheat, barley, rye and other grains that contain gluten-related ...
(Date:6/19/2013)... A Cornell University study offers further proof that the ... 6 million years ago was profoundly influenced by mutations ... on and off. , The study, published June 9 ... 40-year-old hypothesis that regulation of genes must play an ... between humans and chimps in the proteins produced by ...
(Date:6/19/2013)... 2013 Elsevier, a world-leading provider of scientific, technical ... announce the launch of a new open access journal, ... GeoResJ , Elsevier,s earth and planetary science journals ... journal aims to provide a forum for rapid publication ... The journal will be co-edited by six Executive Editors, ...
Breaking Biology News(10 mins):New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3
... genetic diversity in crops is traditional practice for agriculture ... develop breeding programs with great care for the security ... numerous risks the world,s food supplies face with the ... essential as an insurance against unforeseeable changes in the ...
... -- A Duke University-led team has brought powerful software ... Working together, computer scientists and biochemists have developed and ... to change the machinery that bacteria use to make ... set of computer rules known as the algorithm "K*" ...
... distinguishes itself as the fastest growing greenhouse gas in ... emissions depends on our ability to measure the increase ... increase. Until the late 1950s when high ... whether the industrial revolution and the associated increase in ...
Cached Biology News:Identifying mega-targets for high-yield plant breeding 2Duke software dramatically speeds enzyme design 2Duke software dramatically speeds enzyme design 3Carbon accounting from atmospheric measurements -- the aircraft perspective 2
... ideal for use as source plates for arraying ... to 5µl). These plates are available either with ... Features 384 round wells Cylindrical ... volume (cylindrical well), 55µl well volume (V well) ...
... Reagent A - Fixation medium Reagent B ... intended for fixing cells in suspension with ... with Reagent B. This procedure gives antibodies ... morphological scatter characteristics of the cells intact. ...
... Rabbit polyclonal to JNK1 (phospho T183 + Y185) ... internal domain containing phosphorylated T183/Y185. Reactivity / ... Not yet tested in other species. Background ... including the ERK, JNK, and p38 kinases. The ...
... Dako Target Retrieval Solution, pH 9 (x ... buffer, pH 9, intended for heat-induced target ... is well-suited for use on formalin-fixed, paraffin-embedded ... with 0.01 mol/L citrate buffer, pH 6, ...
Biology Products: